Synopsys (SNPS) in Pivotal Point Check: AI Monopoly in Chip Design - Mega Deals with AWS and OpenAI Boost Revenue Forecast to $11.2 Billion!
Reading Time: 2 minutes
Billion-Dollar Deal with AWS: Multi-year licensing agreement with Amazon Web Services for the development of customized AI processors. Strategic OpenAI Alliance: The platform "GPT-Synopsys" utilizes advanced AI models to accelerate the design of highly complex microchips. Optimistic Long-term Outlook: Revised forecast for fiscal year 2027 and a stock buyback program of $1 billion significantly exceed analysts' expectations. Synopsys, the world's leading company for software used in the development and verification of microchips...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
